Abdulrab Ahmed M Alkhanjaf

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 5

Top Topics

Physical Activity

Anti Inflammatory

Top Venues

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Abdulrab Ahmed M Alkhanjaf, Md Tanwir Athar, Zabih Ullah, Abdullah Mohammed H Alsayhab, Ahmad Umar, Ibrahim Ahmed Shaikh
Farnesol Protects against Cardiotoxicity Caused by Doxorubicin-Induced Stress, Inflammation, and Cell Death: An In Vivo Study in Wistar Rats. Molecules (Basel, Switzerland) 27 (23) (2022)
Abdulrab Ahmed M Alkhanjaf, Md Tanwir Athar, Zabih Ullah, Abdullah Mohammed H Alsayhab, Ahmad Umar, Ibrahim Ahmed Shaikh
Farnesol Protects against Cardiotoxicity Caused by Doxorubicin-Induced Stress, Inflammation, and Cell Death: An In Vivo Study in Wistar Rats. Molecules (Basel, Switzerland) 27 (23) (2022)
Abdulrab Ahmed M Alkhanjaf, Md Tanwir Athar, Zabih Ullah, Abdullah Mohammed H Alsayhab, Ahmad Umar, Ibrahim Ahmed Shaikh
Farnesol Protects against Cardiotoxicity Caused by Doxorubicin-Induced Stress, Inflammation, and Cell Death: An In Vivo Study in Wistar Rats. Molecules (Basel, Switzerland) 27 (23) (2022)
Abdulrab Ahmed M Alkhanjaf, Md Tanwir Athar, Zabih Ullah, Abdullah Mohammed H Alsayhab, Ahmad Umar, Ibrahim Ahmed Shaikh
Farnesol Protects against Cardiotoxicity Caused by Doxorubicin-Induced Stress, Inflammation, and Cell Death: An In Vivo Study in Wistar Rats. Molecules (Basel, Switzerland) 27 (23) (2022)
Abdulrab Ahmed M Alkhanjaf, Md Tanwir Athar, Zabih Ullah, Abdullah Mohammed H Alsayhab, Ahmad Umar, Ibrahim Ahmed Shaikh
Farnesol Protects against Cardiotoxicity Caused by Doxorubicin-Induced Stress, Inflammation, and Cell Death: An In Vivo Study in Wistar Rats. Molecules (Basel, Switzerland) 27 (23) (2022)